Australian government
ESHG: High-Risk Pediatric Cancer Survival More Than Doubles in Australian Precision Medicine Trial
Premium
More than 40 percent of patients in the Zero Childhood Cancer precision medicine program received a treatment recommendation based on their multiomic profiling results.
Garvan Institute Gets A$11.6M From Australian Government to Develop Genomics-Based Disease Tests
Four teams will use genomics to improve the diagnosis and treatment of diseases including Parkinson's, inflammatory bowel disease, and rare genetic disorders.
Australian Government Invests A$28.1M to Establish Genomics Agency
The new agency, Genomics Australia, will be tasked with supporting the integration of genomic medicine into Australia's healthcare system.
Melbourne Genomics Health Alliance to Receive A$36M in New Government Funding
The alliance of hospitals, research groups, and academic institutes is tasked with implementing clinical genomics programs in Australia's state of Victoria.
GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx in Australia
A pilot study enrolling up to 15 patients will validate CapeDx's utility to match patients to approved drugs and clinical trials based on whole-genome and tumor sequencing.